A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes. Researchers with City of Hope, one of the largest and most advanced cancer research and ...
Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient’s likely response to chimeric antigen receptor (CAR) T cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback